Collins Helen Louise

Kura Oncology, Inc. · Director

Collins Helen Louise is listed in public filings as director. This Collins Helen Louise insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Kura Oncology, Inc. (KURA), Enliven Therapeutics, Inc. (ELVN), and IO Biotech, Inc. (IOBT). Investors use Collins Helen Louise's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Trades

CompanyValueActionPriceCurrent Price
Enliven Therapeutics, Inc.ELVN$137k3.5k sharesSellMay 18, 2026$39.53--
Enliven Therapeutics, Inc.ELVN$52k1.3k sharesSellMay 18, 2026$40.25--
Enliven Therapeutics, Inc.ELVN$9.2k223 sharesSellMay 18, 2026$41.21--